Bank Maspion Indonesia Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Bank Maspion Indonesia Tbk. trades at Rp476 (market cap 8.49T, 6.6K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 715.5B, 30.64M 24h volume). The key difference: Bank Maspion Indonesia Tbk. is far larger — about 11.9× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (30.64M versus 6.6K). Which is the better fit depends on your goals.
| BMAS | RSCH | |
|---|---|---|
Market Cap | 8.49T | 715.5B |
Volume | 6.6K | 30.64M |
Lot | 66 | 306.41K |
Turnover | 3.12M | 7.98B |
Average Price | 472.15 | 260.34 |
Value | 3.12M | 7.98B |
Indicative Equilibrium Price | — | 256 |
Indicative Equilibrium Volume | — | 512 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Maspion Indonesia Tbk (the Bank) was established on November 6, 1989 based on Notarial Deed No. 68 of Soetjipto, S.H., which was amended by Notarial Deed No. 49 dated December 5, 1989 of the same notary. The Bank started its commercial operations in 1990. As of December 31, 2012, the Bank has 10 domestic branches, 27 sub-branches, 10 cash offices and 45 Automatic Teller Machines (ATMs) located at Surabaya, Jakarta, Semarang, Denpasar, Medan, Bandung, Makassar, Malang, Solo and Purwokerto.
Read more on BMAS →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →